Integra LifeSciences Holdings (IART) Total Assets by Year
Integra LifeSciences Holdings closed fiscal year 2025 with $3.6B in total assets, $2.6B in total liabilities and $1.0B in shareholder equity. This represents a decrease of 10.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Integra LifeSciences Holdings has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IART Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6B-10.8% | $4.0B+6.8% | $3.8B-2.8% | $3.9B+2.8% | $3.8B+4.6% | $3.6B+9.4% | $3.3B+6.3% | $3.1B-3.2% | $3.2B+77.6% | $1.8B+1.9% | $1.8B+11.8% | $1.6B+33.2% | $1.2B+2.5% | $1.2B+1.7% | $1.1B |
| Total Liabilities | $2.6B+2.7% | $2.5B+13.6% | $2.2B+5.2% | $2.1B-0.6% | $2.1B-0.1% | $2.1B+11.3% | $1.9B+8.9% | $1.7B-23.0% | $2.2B+132.3% | $968.3M-5.3% | $1.0B+15.8% | $883.1M+67.9% | $526.0M-18.5% | $645.8M-0.9% | $651.5M |
| Total Equity | $1.0B-32.5% | $1.5B-2.7% | $1.6B-12.0% | $1.8B+7.1% | $1.7B+11.2% | $1.5B+6.9% | $1.4B+3.0% | $1.4B+43.0% | $962.3M+14.6% | $839.7M+11.7% | $751.4M+6.7% | $704.3M+5.7% | $666.1M+28.6% | $517.8M+5.1% | $492.6M |
IART Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6B-2.8% | $3.6B-11.7% | $3.6B-10.8% | $3.6B-10.3% | $3.7B-10.0% | $4.1B-0.6% | $4.0B+6.8% | $4.1B+8.7% | $4.1B+7.9% | $4.1B+9.0% | $3.8B-2.8% | $3.7B-1.8% |
| Total Liabilities | $2.5B-4.2% | $2.5B+0.3% | $2.6B+2.7% | $2.6B+2.5% | $2.6B+3.5% | $2.5B+1.9% | $2.5B+13.6% | $2.5B+17.8% | $2.5B+21.3% | $2.5B+20.0% | $2.2B+5.2% | $2.2B+3.7% |
| Total Equity | $1.0B+0.5% | $1.0B-31.6% | $1.0B-32.5% | $1.0B-31.8% | $1.0B-32.3% | $1.5B-4.6% | $1.5B-2.7% | $1.5B-3.6% | $1.5B-8.9% | $1.6B-4.6% | $1.6B-12.0% | $1.6B-8.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Integra LifeSciences Holdings financials
Frequently Asked Questions
What was Integra LifeSciences Holdings's total assets in fiscal year 2025?
Integra LifeSciences Holdings closed fiscal year 2025 with $3.6B in total assets, $2.6B in total liabilities and $1.0B in shareholder equity.
How fast is Integra LifeSciences Holdings's total assets growing?
Integra LifeSciences Holdings (IART) total assets fell by 10.8% year over year, from $4.0B to $3.6B in fiscal year 2025.
How has Integra LifeSciences Holdings's total assets changed over the years?
Across the 15 fiscal years this page covers, Integra LifeSciences Holdings (IART) total assets went from $1.1B in fiscal year 2011 to $3.6B in fiscal year 2025.
What was Integra LifeSciences Holdings's total assets in the most recent quarter?
Integra LifeSciences Holdings (IART) reported $3.6B in total assets in Q2 2026. This represents a decrease of 2.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Integra LifeSciences Holdings (IART) reported on that line in every period on record.